A recent prospective observational study of 507 patients with first-ever ischemic stroke showed that treatment with ACEI at the time of stroke onset is associated with reduced plasma concentration of C-reactive protein and better long-term outcomes [13], suggesting that ACEI may have anti-inflammatory properties and reduce the acute-phase inflammatory response after stroke onset. Here, CRP is linked to ischemic stroke.